Children’s Miracle Network at UC Davis awards 16 grants totaling more than $1.6 million

Sixteen grants, totaling $1,615,965.00, have been recently awarded by Children’s Miracle Network at UC Davis to clinicians and researchers at UC Davis Children’s Hospital. Grants in the amount of $1,286,739.00 will enhance the clinical care of children, while $329,226.00 was awarded for research directly improving the health and welfare of children.

Each fiscal year, applications are accepted by Children’s Miracle Network (CMN) for both clinical services and research grants. Each application must demonstrate how the project or research contributes to UC Davis Health strategic goals or UC Davis Medical Center institutional goals. The amount awarded each year is determined by the CMN Executive Committee and Chief Executive Officer of UC Davis Medical Center.

Clinical services grants:

• Virtual Reality in Pediatrics: An Evidence-Based Strategy for Pain and Anxiety Reduction: Norena Banayat
• Inpatient Auditory Brainstem Response Testing Equipment: Aditi Bhuskute
• Point-of-Care International Normalized Ratio (INR) Blood Test for Warfarin Patients: Robin Culver
• Pediatric Intensive Care Unit Mock Code Program: Ashley Donkerbrook
• Removing Barriers to care for Pediatric Ophthalmology Patients: Marcela Estrada
• Providing Safe Breastmilk Transportation for NICU Families and Enhancing Lactation Support to Improve Neonatal Outcomes: Erica Helmer
• Clínica de Revisión de Etapas de Crecimiento en Español (CRECE) Clinic Grant: Rosa Rodriguez
• MIND Institute Child Life Sibling Support Programs: Veronica Tuss
• Pain Clinic – Pediatric Specialty Mental Health Integration Pilot: John Standish Adams
• PATH – A Path to Positive Medical Outcomes (Promoting Accessibility to Healthcare): Roger Scott Akins
• Respiratory Therapist-Guided Case Management and Continuity of Care – A Novel Approach to Hospitalized Children on Long-term Ventilation: Rory Kamerman-Kretzmer
• YMCA – Healthy US! Health-based Summer Camp: Sindhura Batchu

Research grants:

• Randomized Pilot Trial of Dopamine vs Norepinephrine in Persistent Pulmonary Hypertension of Newborn (DONE Trial): Deepika Sankaran
• Functional Genomic Analysis of Protein Tyrosine Phosphatase Non-Receptor Type 14 (PTPN14) as a Molecular Marker of Vascular Disease: Daniah Beleford
• Improving Screening and Identification of Development Concerns in Infants from Spanish-speaking Families: Meagan Talbott
• Fontan Failure Prediction via Abdominal-Thoracic Impedance Changes and Vectorcardiography: Daniel Cortez